CK Group’s Post

𝗚𝗲𝗻𝗲 𝗘𝘅𝗽𝗿𝗲𝘀𝘀𝗶𝗼𝗻 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟮. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 The Gene Expression market is poised for substantial growth during the forecast period, primarily fueled by an increasing number of cancer patients, improved financial funding facilities, reduced sequencing costs, and heightened focus on research and development. Emerging economies present favorable opportunities for industry expansion, driven by a growing emphasis on adoption, precision, and personalization in medicines. However, challenges such as currency devaluation in developing nations and the initial capital investment required for various instruments act as restraints. The report provides an overview of the Gene Expression industry chain, analyzing the market status of Drug Discovery (Consumables, Instruments) and Diagnostics (Consumables, Instruments), alongside key enterprises in developed and developing markets. It also delves into cutting-edge technology, patents, hot applications, and market trends within the Gene Expression sector. Regionally, North America and Europe witness steady growth due to government initiatives and heightened consumer awareness, while Asia-Pacific, particularly China, leads the global market with strong domestic demand, supportive policies, and a robust manufacturing base. Key features of the report include a comprehensive understanding of the Gene Expression market, offering holistic insights into the industry and detailed analyses of market dynamics, trends, challenges, and opportunities. 𝗧𝗼 𝗞𝗻𝗼𝘄 𝗚𝗹𝗼𝗯𝗮𝗹 𝗦𝗰𝗼𝗽𝗲 𝗮𝗻𝗱 𝗗𝗲𝗺𝗮𝗻𝗱 𝗼𝗳 𝗚𝗲𝗻𝗲 𝗘𝘅𝗽𝗿𝗲𝘀𝘀𝗶𝗼𝗻 𝗠𝗮𝗿𝗸𝗲𝘁.𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/dDSTPhzu *𝗕𝘆 𝗧𝘆𝗽𝗲: Consumables,  Instruments *𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: Drug Discovery,  Diagnostics *𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa *𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: Agilent Technologies,  Bio-Rad Laboratories,  F. Hoffmann-La Roche Ltd,  Thermo Fisher Scientific #geneexpression #biotechnology #genomics #research #molecularbiology #biomedicalresearch #genetics #healthcaretechnology #biomarkers #biopharmaceuticals #precisionmedicine #medicalresearch #transcriptomics #geneanalysis #geneticresearch #clinicaltrials #drugdiscovery #precisiononcology #biomarkerdiscovery #lifesciences #innovation

The global biotechnology market was valued at USD 1.55 Trillion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 13.96% from 2024 to 2030. According to industry analysts, this robust growth outlook reflects increasing investments in gene and cell therapies, recombinant DNA technologies, and bio-manufacturing. As innovative new biologic treatments and diagnostics continue to enter the clinic and marketplace, the economic potential of the biotechnology sector is likely to further accelerate. With numerous companies developing transformative medicines and technologies, the industry's total worth could surpass estimates to reach unprecedented heights by the end of the decade. #swissmen #research #biotech #data #duediligence #insights

One of my favorite topics, in a summarized form. Reach out if you'd like to learn more and discuss further on how we can use network approaches in drug discovery. #networkbiology #computationalbiology #machinelearning #drugdiscovery

Once confined mainly to large life science multinationals, there has been a recent explosion in demand for RPO solutions across small to midsized companies including entrepreneurial new start-ups in innovative areas from gene therapy to biotech. Discover what procurement leaders should be looking for in an RPO (or Direct Sourcing) supplier within the Life Sciences arena and what steps should be taken in the selection process to ensure a successful relationship. https://lnkd.in/eqs7kszu #LifeSciences #Recruitment #Procurement #SkillsAlliance

Stay informed about the latest trends in the Cell And Gene Therapy Manufacturing Market with the latest report from 👤IMIR Market Research Pvt. Ltd. Cell And Gene Therapy Manufacturing Market Size, Share & Trends Analysis Report By Type, By Indication, By Application, By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Other End Users), Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2031. 📚𝐆𝐞𝐭 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐀𝐭 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭𝐞𝐝 𝐏𝐫𝐢𝐜𝐞:📝👇 The report covers various regions, including:  #NorthAmerica #Europe #AsiaPacific #LatinAmerica and #Africa. Don't miss out on this opportunity to stay informed about the latest trends in the industry. 📚𝐑𝐞𝐩𝐨𝐫𝐭 𝐅𝐨𝐜𝐮𝐬𝐞𝐝 𝐎𝐧 𝐓𝐨𝐩 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬:👇 Pharmatech Associates, a USP company Porton Advanced │ Cell & Gene Therapy CDMO/CRO Roche Samsung Biologics Sana Biotechnology, Inc. Sartorius Sartorius CellGenix GmbH SCTbio SIRION BIOTECH GmbH (Revvity Gene Delivery) SK pharmteco Solentim Spark Therapeutics, Inc. Stevenage Bioscience Catalyst Syner-G BioPharma Group Takara Bio USA, Inc. Teknova TEVOGEN BIO Texcell Thermo Fisher Scientific ThermoGenesis Holdings, Inc. uBriGene Biosciences International Co. United Consulting Hub VintaBio WuXi Advanced Therapies WuXi AppTec Xellera Therapeutics Xihua Pharma #CellAndGeneTherapy #Manufacturing #Intellectualmarketinsightresearch #Marketresearchreports #Size #Share #Trends #Growth #Opportunity #Outlook #Forecast #Covid19 #Segments #KeyPlayers #RegionsOutlook #GrowthPotential #PriceTrends #CompetitiveMarket #Forecast #2023To2031

Another promising biotech faces challenges: Tome Biosciences is laying off its entire workforce and winding down operations, just months after raising $213M. This highlights the growing difficulties faced by gene-editing and preclinical-stage companies across the industry. Despite promising technology, showing proof of concept quickly while derisking manufacturing and market challenges is a priority in order to secure continued financing. Tome is a stark reminder of these hurdles. Clora has supported biotechs in similar constraints through innovative operating models. Teams are able to extend runway and reach successful clinical outcomes faster. Read more here: https://ow.ly/RY0c50TfIKr #Clora #geneediting #biotech #lifesciences #genetherapy #celltherapy

We are excited to share that Nature Biotechnology highlighted Empress Therapeutics as a top startup! We were recognized for the breakthrough principle of using co-evolution to guide the discovery of drugs by finding biologically active small molecules encoded in human metagenomic data. Empress scientists estimate that 10^24 possible chemical compounds have been made and tested inside the bodies of humans by co-evolved microbial chemists – greater than any in silico or physical library, and with the added advantages of built-in human relevance and compatibility. We analyze genes encoding biosynthetic pathways that make these compounds to draw associations with health or disease, then use AI and synthetic biology to generate drug leads from gene data. The impact? Predictability and speed in small molecule drug discovery. Read the article to learn more: https://lnkd.in/gsZ-kPqc #FlagshipFounded #Chemilogics #smallmolecule #drugdiscovery #AI #synbio

Empress Therapeutics recognized as a top biotech startup for rethinking small molecule drug discovery! Thanks Barbara Cheifet for the Editor’s Pick and Michael Eisenstein for a great summary of our #Chemilogics platform and the underlying principle that the co-evolutionary forces that shaped humans' symbiotic relationship with microbes selected for, and encoded into gene data, compounds with potency, specificity, and other drug-like properties against a wide range of disease mechanisms. Starting with these genetically encoded, biologically active, and physiologically compatible compounds provides a privileged & advanced starting point for generating novel medicines. We get to take this evolutionary head start to develop first in class medicines for patients!

Advanced Therapies Week is here and I couldn't be more excited! As part of the Planet Innovation Round Table, my colleague Brian Hanrahan and I have released an article on "Effective strategies for securing investor funding in cell and gene manufacturing tools development". Our article delves into the industry's view on the differentiated value of new tools and technology for potential adopters. Check out the link below for more insights on this fascinating topic! #advancedtherapies #celltherapy #genetherapy #cellandgenetherapy #regenerativemedicine #biotech #biotechnology #diagnostics #pharma #pharmaceuticals #lifesciences #healthcare #tools #technologies #digital #software #designanddevelopment #outsourcing #partnerships #investment #attractinginvestment #milestones #differentiation #valueproposition #investors #strategy #execution #teams